yongchoon ang's comment on MTRONIC. All Comments

yongchoon ang
7 Like · Reply
坚持住别卖,大家加码把它推上去,疫苗股都涨了,这里要开始了,大家加油
yongchoon ang
加码加码,这趟财富列车没上的不要哭哦
2 Like · 3 months · translate
Confirm Mr
Confirmed dy.....
1 Like · 3 months · translate
Chin Yih Kam
一起加油!繼續建倉ing
Like · 3 months · translate
黃秀蘭
真的嗎 我被套在高處 如果是真的我想average down
1 Like · 3 months · translate
James See
如果你真的中套然后想average down倒不如拿一部分钱买solutn找好的买点进场。起跌快赚比较快。你average down又去横盘然后到0.2的人也会解套快快卖。个人认为
1 Like · 3 months · translate
Dyran Hau
万一这边炒上去那边跌呢?有些东西无法预知的?而且这个股还算很便宜呢
1 Like · 3 months · translate
james see
哈哈哈。。也不错的。。0.115 to 0.2有 0.085赚。
Like · 3 months · translate
james see
这个股只在马来西亚卖。如果malaysia不approve mRNA他就这样gg.com....solution还有机会在其他国家卖。你可以对比看看那个比较有利可图。
Like · 3 months · translate
james see
mtronicWe refer to your Company’s announcement dated 20 November 2020, in respect of the aforesaid matter.
 
In this connection, kindly furnish Bursa Securities with the following additional information for public release:-

The relevant regulatory approvals required to be obtained before Metronic can commence  the distributorship under the Finished Product Model and Fill and Distribution Model of MVC’s COVID-19 vaccine in Malaysia and the estimated time-frame for submission of such applications
Show more
Like · 3 months · translate
james see
solution refer to the Company’s announcements dated 19 August 2020, 24 August 2020, 27 August 2020, 2 September 2020, 23 September 2020 and 24 September 2020.  The Board of Directors of Solution Group Berhad (“Board”) wishes to announce that our subsidiary, Solution Biologics Sdn Bhd (“SOLBIO”), had on 30 October 2020 received a Letter of Authorisation (“LOA”) from CanSino Biologics Inc. (“CanSino”, SHSE: 688185, HKEX:06185).

CanSino has authorized SOLBIO to develop the business in Philippines,
Show more
Like · 3 months · translate
james see
CanSino has authorized SOLBIO to develop the business in Philippines, Vietnam, Thailand, Myanmar, Cambodia, Laos and Brunei (“Territory”), for their Recombinant Novel Coronavirus Vaccine candidate (Ad5-nCoV) composed of an adenovirus type 5 vector (Bulk Product presentation) (“Bulk Product”), by working with the respective local partners, authorities and regulatory bodies in the Territory in order to prepare the market for the Bulk Product, so that the Product can be sold when it is approved.

 
Show more
Like · 3 months · translate